fashion -WSS

fashion

author：focus 2025-10-01 17:19:23 - browse：9138

A dosage of Wegovy, a drug used for weight loss — Amanda Andrade-Rhoades/AP

U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment.

The new label indicates that Wegovy can be used to reduce the risk of major heart complications — including heart attack, stroke, or cardiovascular-related deaths — for people with overweight or obesity and existing heart disease, Novo said in a statement Friday.

The decision was based on results of a large, five-year trial that showed Wegovy cut the risk of cardiovascular problems by 20% in that population. This is the first time a weight loss treatment has been approved to also help improve heart outcomes, the FDA said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Oak Street deal isn't the answer to health care's woes

hotspot

WSS

Intellia plays down concerns on accidental germline transmission

Health officials lay out plans to cope with respiratory virus season

PBMs are inflating the cost of generic drugs. They must be reined in

CVS is willing to dump 10% of its Medicare Advantage members

Study: Spinal cord stimulation helps patients with paralysis walk again

WuXi Biologics beefs up its lobbying operation

knowledge

fashion

leisure time

Jerome Adams on the need for new antivirals for Covid

How to make over

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Guidelines to prevent youth baseball injuries need more muscle

As obesity drug market grows, telehealth companies court payers

Drug repurposing or repositioning? The language matters

Lilly’s weekly insulin works as well as daily products, new studies show

Trump demands the U.S. pay no more for drugs than other countries … again

Trans patients at the end of life deserve respect and dignity

entertainment

Lilly’s weekly insulin works as well as daily products, new studies show

Intellia plays down concerns on accidental germline transmission

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Cherokee Nation medical school graduates its first class

People can get long Covid without testing positive for virus: Study

STAT series 'Denied by AI' wins major journalism prizes

Wikipedia

knowledge

hotspot

knowledge